Skip to content

Hello, Life Science Baltics!

dHealthIQ team is happy to welcome you to our digital booth and tell you all about our amazing product and our journey to digital therapeutics.

Mindaugas Leonavičius

dHealthIQ Co-Founder

Welcome to dHealthIQ!

In the ever-changing landscape of healthcare, we are here to merge the best digital and healthcare practices thus building a more efficient way to treat chronic patients. By putting the patient first and focusing on enabling personalised therapeutics, dHealthIQ is the easy way to the world of digital health.

Learn more about our product and join us in our booth – we’d love to meet you.

Did you know?

“Digital therapeutics (DTx) deliver medical interventions directly to patients using evidence-based, clinically evaluated software to treat, manage, and prevent a broad spectrum of diseases and disorders.”

22.5 m

people using digital therapeutics
products worldwide in 2020

652.4 m

people expected to use digital therapeutics
products worldwide in 2025

How it works?

Our therapies combine the professional expertise of clinicians with instant intuitive recommendations powered by AI technology to drive the treatment process

With a strong focus on blending pharmaceutical remedies with lifestyle and behavioural modifications, the continuous nature of digital therapeutics motivates patients to improve compliance with their treatment regimens.

Our pipeline of upcoming products includes therapies targeting the cardiometabolic disease area, such as hypertension and cardio rehabilitation.

Why dHealthIQ?

We are a digital health company, enabling healthcare providers to treat and manage chronic cardiometabolic diseases based on evidence-based and personalised interventions directly to the patient.

Our solution has a strong focus on combining pharmaceutical, lifestyle and behavioural components within the treatment process. dHealth approach is unique because:


More sophisticated approach to treatment monitoring is the continuous monitoring of health parameters by devices directly coupled to therapy administration.


Strong background in Deep tech / Data science / AI / ML / Data Analytics, with AI / ML engine being the core component of the solution.


Core strategy to develop and commercialise clinically validated therapeutics. Through well-structured development processes and clinical validation, the commercialisation through reimbursements becomes possible.


Experience with the collaboration between Data Science / Deep Tech and Medical specialists – in development, and projects. Strong partnership with LSMU.

Join us!

If you're interested in digital therapeutics or dHealthIQ - let's talk more. Join us for a chat in our virtual booth, subscribe to our newsletter or follow us on LinkedIn.

All the dHealthIQ news delivered straight to your inbox


Since its founding, dHealthIQ has been devoted to the development of a new type of digital therapeutic, designed for patients with chronic diseases and the clinicians who treat them. Our first product, a digital diabetes therapeutic, will complete clinical trials this fall. Development of a follow-on product, aimed at bringing similar technology and digital health monitoring methodology to cardiometabolic disease, is nearing completion.


Researchers, clinicians, healthcare institutions, and pharmaceutical companies interested in collaborating with dHealth or providing feedback on our products can contact the company at: